Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling

被引:252
作者
Yet, SF
Layne, MD
Liu, XL
Chen, YH
Ith, B
Sibinga, NES
Perrella, MA
机构
[1] Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med, Boston, MA 02115 USA
[2] Kaohsiung Med Univ, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Cardiovasc, Bronx, NY 10467 USA
关键词
atherosclerosis; vein graft; pressure overload; oxidative stress;
D O I
10.1096/fj.03-0187fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To examine the role of hemeoxygenase(HO)-1 in the pathophysiology of vascular diseases,we generated mice deficient in both HO-1 and apolipoprotein E( HO-1(-/-)apoE(-/-)). Despite similar total plasma cholesterol levels in response to hypercholesterolemia, HO-1-/-apoE-/-mice, in comparison with HO-1(+/+) apoE(-/-) mice, had an accelerated and more advanced atherosclerotic lesion formation. In addition to greater lipid accumulation, these advanced lesions from HO-1(-/-) apoE(-/-) mice contained macrophages and smooth muscle alpha-actin-positive cells. We further tested the role of HO-1 on neointimal formation in a mouse model of vein graft stenosis. Autologous vein grafts in HO-1(-/-) mice showed robust neointima consisting of alpha-actin-positive vascular smooth muscle cells(VSMC) 10 days after surgery in comparison to the smaller neointima formed in autologous vein grafts in HO-1(+/+) mice. However, at 14 days after surgery, the neointima from composite vessels of HO-1(-/-) mice was composed mainly of acellular material, indicative of substantial VSMC death. VSMC isolated from HO-1(-/-) mice were susceptible to oxidant stress, leading to cell death. Our data demonstrate that HO-1 plays an essential protective role in the pathophysiology of atherosclerosis and vein graft stenosis.
引用
收藏
页码:1759 / +
页数:19
相关论文
共 52 条
[11]  
Hishikawa K, 1997, CIRC RES, V81, P797
[12]   Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease [J].
Hopkins, PN ;
Wu, LL ;
Hunt, SC ;
James, BC ;
Vincent, GM ;
Williams, RR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (02) :250-255
[13]   Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study [J].
Hunt, SC ;
Kronenberg, F ;
Eckfeldt, JH ;
Hopkins, PN ;
Myers, RH ;
Heiss, G .
ATHEROSCLEROSIS, 2001, 154 (03) :747-754
[14]   Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits [J].
Ishikawa, K ;
Sugawara, D ;
Goto, J ;
Watanabe, Y ;
Kawamura, K ;
Shiomi, M ;
Itabe, H ;
Maruyama, Y .
CIRCULATION, 2001, 104 (15) :1831-1836
[15]   Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice [J].
Ishikawa, K ;
Sugawara, D ;
Wang, X ;
Suzuki, K ;
Itabe, H ;
Maruyama, Y ;
Lusis, AJ .
CIRCULATION RESEARCH, 2001, 88 (05) :506-512
[16]   Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL [J].
Ishikawa, K ;
Navab, M ;
Leitinger, N ;
Fogelman, AM ;
Lusis, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1209-1216
[17]   Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse [J].
Johnson, JL ;
Jackson, CL .
ATHEROSCLEROSIS, 2001, 154 (02) :399-406
[18]   Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice [J].
Juan, SH ;
Lee, TS ;
Tseng, KW ;
Liou, JY ;
Shyue, SK ;
Wu, KK ;
Chau, LY .
CIRCULATION, 2001, 104 (13) :1519-1525
[19]   RAPIDLY OCCURRING DNA EXCISION REPAIR EVENTS DETERMINE THE BIOLOGICAL EXPRESSION OF UV-INDUCED DAMAGE IN HUMAN-CELLS [J].
KEYSE, SM ;
TYRRELL, RM .
CARCINOGENESIS, 1987, 8 (09) :1251-1256
[20]   Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts [J].
Kockx, MM ;
DeMeyer, GRY ;
Bortier, H ;
deMeyere, N ;
Muhring, J ;
Bakker, A ;
Jacob, W ;
VanVaeck, L ;
Herman, A .
CIRCULATION, 1996, 94 (06) :1255-1262